Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinitis pigmentosa in which the cause of the disease is a mutation in the RGR gene.
Features include: Constriction of peripheral visual field, Visual impairment, Rod-cone dystrophy, and Attenuation of retinal blood vessels and 1 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 2 | Visual impairment, Attenuation of retinal blood vessels |
RGR function has not been fully characterized.
Retinitis pigmentosa 44 is associated with mutations in the RGR gene on chromosome 10.
Genetic testing for RGR is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for retinitis pigmentosa 44 has been reported in the published literature.
No clinical trials have been registered for retinitis pigmentosa 44.
68 publications have been identified in PubMed for retinitis pigmentosa 44. Research spans Basic Science / Preclinical (29%), Epidemiology / Natural History (24%), and Diagnostic / Biomarker (13%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 20 | 29% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 5:36 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
16 |
24% |
Testing and diagnosis research | 9 | 13% |
Clinical study results | 7 | 10% |
Patient case studies | 6 | 9% |
Research summaries | 5 | 7% |
New treatment approaches | 3 | 4% |
Other research | 2 | 3% |
de Guimarães TAC (2026). [PMID: 42071308](https://pubmed.ncbi.nlm.nih.gov/42071308/). *Ophthalmic Genet*. [Diagnostic / Biomarker]
Chentoufi FE (2026). [PMID: 40389825](https://pubmed.ncbi.nlm.nih.gov/40389825/). *J Biomol Struct Dyn*. [Basic Science / Preclinical]
Mahler EA (2026). [PMID: 41238926](https://pubmed.ncbi.nlm.nih.gov/41238926/). *Ophthalmologie*. [Basic Science / Preclinical]
Bailey JA (2026). [PMID: 41491338](https://pubmed.ncbi.nlm.nih.gov/41491338/). *Doc Ophthalmol*. [Case Report / Case Series]
Li S (2026). [PMID: 41775632](https://pubmed.ncbi.nlm.nih.gov/41775632/). *J Neurosci*. [Basic Science / Preclinical]
Koizumi H (2026). [PMID: 41898848](https://pubmed.ncbi.nlm.nih.gov/41898848/). *Genes (Basel)*. [Basic Science / Preclinical]
Yates S (2026). [PMID: 42064015](https://pubmed.ncbi.nlm.nih.gov/42064015/). *Ophthalmol Sci*. [Diagnostic / Biomarker]
Parekh BJ (2026). [PMID: 41760091](https://pubmed.ncbi.nlm.nih.gov/41760091/). *Clin Exp Ophthalmol*. [Epidemiology / Natural History]
El Khair K (2026). [PMID: 40892044](https://pubmed.ncbi.nlm.nih.gov/40892044/). *J Biomol Struct Dyn*. [Basic Science / Preclinical]
Aychoua N (2026). [PMID: 41296346](https://pubmed.ncbi.nlm.nih.gov/41296346/). *JAMA Ophthalmol*. [Basic Science / Preclinical]